News & Updates
Filter by Specialty:
Local data support continuation of RASIs in patients with T2D and advanced CKD
Discontinuation of renin-angiotensin system inhibitors (RASIs) is associated with higher risks of cardiorenal complications and neutral risk of all-cause mortality in patients with type 2 diabetes (T2D) and advanced chronic kidney disease (CKD), according to researchers from the Chinese University of Hong Kong (CUHK).
Local data support continuation of RASIs in patients with T2D and advanced CKD
22 Dec 2022
HF meds rapid up-titration reduces readmission, mortality after acute HF hospitalization
Rapidly maximizing medications in patients discharged from hospital following acute heart failure (AHF) reduced the risk of hospital readmission or death at 180 days, according to results of the STRONG-HF* trial presented at AHA 2022.
HF meds rapid up-titration reduces readmission, mortality after acute HF hospitalization
21 Dec 2022
5-fraction SBRT improves outcomes in osseous renal cell carcinoma metastases
Local-control outcomes are encouraging in patients with osseous renal cell carcinoma metastases who went through five fractions of stereotactic body radiotherapy (SBRT), reports a study.
5-fraction SBRT improves outcomes in osseous renal cell carcinoma metastases
21 Dec 2022
Female, male infertility: Adherence to anti-inflammatory diets may bring new babies
Anti-inflammatory dietary patterns, such as the Mediterranean diet, may improve the chances of conception among couples who struggle with infertility, according to a recent review.
Female, male infertility: Adherence to anti-inflammatory diets may bring new babies
21 Dec 2022
Obesity associated with adverse ITP outcomes
In a study presented at ASH 2022, obesity was found to be associated with adverse outcomes in individuals with primary immune thrombocytopenia (ITP; formerly known as thrombocytopenia purpura).
Obesity associated with adverse ITP outcomes
21 Dec 2022
Obesity, overweight up risk of complications from radical cystectomy
Body mass index is independently associated with the development of complications from radical cystectomy, reports a study. Compared to patients with normal BMI, those who are overweight and obese have a higher risk.
Obesity, overweight up risk of complications from radical cystectomy
20 Dec 2022
EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC
In the updated analysis of the phase III EMERALD trial, the next-generation oral SERD* elacestrant continued to show favourable signals for the treatment of ER+/HER2– metastatic breast cancer (mBC).